Enhanced cellular uptake of H-chain human ferritin containing gold nanoparticles
Author
dc.contributor.author
Moglia Fernández, Ítalo Arnoldo
Author
dc.contributor.author
Margarita, Santiago
Author
dc.contributor.author
Guerrero, Simón
Author
dc.contributor.author
Soler Jauma, Mónica
Author
dc.contributor.author
Olivera Nappa, Alvaro María
Author
dc.contributor.author
Kogan, Marcelo Javier
Admission date
dc.date.accessioned
2022-04-20T15:09:19Z
Available date
dc.date.available
2022-04-20T15:09:19Z
Publication date
dc.date.issued
2021
Cita de ítem
dc.identifier.citation
Pharmaceutics 2021, 13, 1966
es_ES
Identifier
dc.identifier.other
10.3390/pharmaceutics13111966
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/185006
Abstract
dc.description.abstract
Gold nanoparticles (AuNP) capped with biocompatible layers have functional optical, chemical, and biological properties as theranostic agents in biomedicine. The ferritin protein containing in situ synthesized AuNPs has been successfully used as an effective and completely biocompatible nanocarrier for AuNPs in human cell lines and animal experiments in vivo. Ferritin can be uptaken by different cell types through receptor-mediated endocytosis. Despite these advantages, few efforts have been made to evaluate the toxicity and cellular internalization of AuNP-containing ferritin nanocages. In this work, we study the potential of human heavy-chain (H) and light-chain (L) ferritin homopolymers as nanoreactors to synthesize AuNPs and their cytotoxicity and cellular uptake in different cell lines. The results show very low toxicity of ferritin-encapsulated AuNPs on different human cell lines and demonstrate that efficient cellular ferritin uptake depends on the specific H or L protein chains forming the ferritin protein cage and the presence or absence of metallic cargo. Cargo-devoid apoferritin is poorly internalized in all cell lines, and the highest ferritin uptake was achieved with AuNP-loaded H-ferritin homopolymers in transferrin-receptor-rich cell lines, showing more than seven times more uptake than apoferritin.
es_ES
Patrocinador
dc.description.sponsorship
Fondap 15130011
Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)
CONICYT FONDECYT 1211482
PIA FB0001
3190297
Fondequip EQM160157
EQM 170111
es_ES
Lenguage
dc.language.iso
en
es_ES
Publisher
dc.publisher
MDPI
es_ES
Type of license
dc.rights
Attribution-NonCommercial-NoDerivs 3.0 United States